{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:51:03Z","timestamp":1769154663575,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T00:00:00Z","timestamp":1398297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Spine J"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00586-014-3317-8","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T10:59:53Z","timestamp":1398250793000},"page":"296-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Late-onset deep surgical-site infection after posterior lumbar interbody fusion in a patient treated with tocilizumab; unusual changes in inflammatory markers"],"prefix":"10.1007","volume":"23","author":[{"given":"Takahiro","family":"Makino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kaito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Yonenobu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,24]]},"reference":[{"key":"3317_CR1","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/ard.2008.092932","volume":"67","author":"P Emery","year":"2008","unstructured":"Emery P, Keystone E, Tony HP, Cantagrel A, van Vollenhoven R, Sanchez A, Alecock E, Lee J, Kremer J (2008) IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis 67:1516\u20131523. doi: 10.1136\/ard.2008.092932","journal-title":"Ann Rheum Dis"},{"key":"3317_CR2","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/ard.2006.068064","volume":"66","author":"N Nishimoto","year":"2007","unstructured":"Nishimoto N, Hashimoto J, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Murata N, van der Heijde D, Kishimoto T (2007) Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an X-ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis 66:1162\u20131167","journal-title":"Ann Rheum Dis"},{"key":"3317_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","volume":"23","author":"T Kishimoto","year":"2005","unstructured":"Kishimoto T (2005) Interleukin-6: from basic science to medicine\u201340\u00a0years in immunology. Annu Rev Immunol 23:1\u201321","journal-title":"Annu Rev Immunol"},{"key":"3317_CR4","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1002\/art.10623","volume":"46","author":"EH Choy","year":"2002","unstructured":"Choy EH, Isenberg DA, Garrood T et al (2002) Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum 46:3143\u20133150","journal-title":"Arthritis Rheum"},{"key":"3317_CR5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","volume":"371","author":"JS Smolen","year":"2008","unstructured":"Smolen JS, Beaulieu A, Rubbert-Roth A et al (2008) Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 371:987\u2013997. doi: 10.1016\/S0140-6736(08)60453-5","journal-title":"Lancet"},{"key":"3317_CR6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/s10165-008-0111-7","volume":"19","author":"H Fujiwara","year":"2009","unstructured":"Fujiwara H, Nishimoto N, Hamano Y, Asanuma N, Miki S, Kasayama S, Suemura M (2009) Masked early symptoms of pneumonia in patients with rheumatoid arthritis during tocilizumab treatment: a report of two cases. Mod Rheumatol 19:64\u201368. doi: 10.1007\/s10165-008-0111-7","journal-title":"Mod Rheumatol"},{"key":"3317_CR7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3109\/s10165-012-0683-0","volume":"23","author":"S Momohara","year":"2013","unstructured":"Momohara S, Hashimoto J, Tsuboi H et al (2013) Analysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: results from the multicentre tocilizumab in perioperative period (TOPP) study. Mod Rheumatol 23:440\u2013449. doi: 10.1007\/s10165-012-0683-0","journal-title":"Mod Rheumatol"},{"key":"3317_CR8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3109\/s10165-011-0459-y","volume":"21","author":"M Hirao","year":"2011","unstructured":"Hirao M, Nampei A, Shi K, Yoshikawa H, Nishimoto N, Hashimoto J (2011) Diagnostic features of mild cellulitis phlegmon in patients with rheumatoid arthritis treated with tocilizumab: a report of two cases. Mod Rheumatol 21:673\u2013677. doi: 10.1007\/s10165-011-0459-y","journal-title":"Mod Rheumatol"},{"key":"3317_CR9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3109\/s10165-009-0159-z","volume":"19","author":"R Nagamine","year":"2009","unstructured":"Nagamine R, Chen W, Hara T, Kondo K, Sugioka Y (2009) Immediate reduction of white blood cell count after tocilizumab administration was observed in some cases. Mod Rheumatol 19:348\u2013350. doi: 10.1007\/s10165-009-0159-z","journal-title":"Mod Rheumatol"},{"key":"3317_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.blo.0000201176.87635.f3","volume":"444","author":"ME Cunningham","year":"2006","unstructured":"Cunningham ME, Girardi F, Papadopoulos EC, Cammisa FP (2006) Spinal infections in patients with compromised immune systems. Clin Orthop Relat Res 444:73\u201382","journal-title":"Clin Orthop Relat Res"},{"key":"3317_CR11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s10067-008-0869-1","volume":"27","author":"S Mori","year":"2008","unstructured":"Mori S, Tomita Y, Horikawa T, Cho I, Sugimoto M (2008) Delayed spinal infection after laminectomy in a patient with rheumatoid arthritis interruptedly exposed to anti-tumor necrosis factor alpha agents. Clin Rheumatol 27:937\u2013939. doi: 10.1007\/s10067-008-0869-1","journal-title":"Clin Rheumatol"},{"key":"3317_CR12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00296-009-0948-x","volume":"30","author":"T Yurube","year":"2010","unstructured":"Yurube T, Takahi K, Owaki H, Fuji T, Kurosaka M, Doita M (2010) Late infection of total knee arthroplasty inflamed by anti-TNFalpha, infliximab therapy in rheumatoid arthritis. Rheumatol Int 30:405\u2013408. doi: 10.1007\/s00296-009-0948-x","journal-title":"Rheumatol Int"},{"key":"3317_CR13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00776-011-0023-9","volume":"16","author":"K Oe","year":"2011","unstructured":"Oe K, Wada T, Ohno H, Kushida T, Iida H (2011) Salmonella septic arthritis following total knee arthroplasty for rheumatoid arthritis in a patient receiving etanercept. J Orthop Sci 16:258\u2013262. doi: 10.1007\/s00776-011-0023-9","journal-title":"J Orthop Sci"},{"key":"3317_CR14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/s10165-009-0197-6","volume":"19","author":"R Koike","year":"2009","unstructured":"Koike R, Harigai M, Atsumi T et al (2009) Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis. Mod Rheumatol 19:351\u2013357. doi: 10.1007\/s10165-009-0197-6","journal-title":"Mod Rheumatol"},{"key":"3317_CR15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3109\/s10165-009-0223-8","volume":"19","author":"T Matsui","year":"2009","unstructured":"Matsui T, Komiya A, Shimada K, Nakayama H, Tohma S (2009) Neutrophil CD64 as a marker of infection in patients treated with tocilizumab. Mod Rheumatol 19:696\u2013697. doi: 10.1007\/s10165-009-0223-8","journal-title":"Mod Rheumatol"},{"key":"3317_CR16","first-page":"114","volume":"35","author":"K Tamaki","year":"2008","unstructured":"Tamaki K, Kogata Y, Sugiyama D et al (2008) Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases. J Rheumatol 35:114\u2013119","journal-title":"J Rheumatol"}],"container-title":["European Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-014-3317-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00586-014-3317-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-014-3317-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T03:27:24Z","timestamp":1559100444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00586-014-3317-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,24]]},"references-count":16,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["3317"],"URL":"https:\/\/doi.org\/10.1007\/s00586-014-3317-8","relation":{},"ISSN":["0940-6719","1432-0932"],"issn-type":[{"value":"0940-6719","type":"print"},{"value":"1432-0932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,24]]}}}